Cargando…

Better influenza vaccines: an industry perspective

Vaccination is the most effective measure at preventing influenza virus infections. However, current seasonal influenza vaccines are only protective against closely matched circulating strains. Even with extensive monitoring and annual reformulation our efforts remain one step behind the rapidly evo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Juine-Ruey, Liu, Yo-Min, Tseng, Yung-Chieh, Ma, Che
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023813/ https://www.ncbi.nlm.nih.gov/pubmed/32059697 http://dx.doi.org/10.1186/s12929-020-0626-6

Ejemplares similares

Clinical Expectations for Better Influenza Virus Vaccines—Perspectives from the Young Investigators’ Point of View
por: Mohn, Kristin G.-I., et al.
Publicado: (2018)

Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine
por: Giurgea, Luca T., et al.
Publicado: (2020)

Universal influenza vaccines: Shifting to better vaccines
por: Berlanda Scorza, Francesco, et al.
Publicado: (2016)

Making Better Influenza Virus Vaccines?
por: Palese, Peter
Publicado: (2006)

Toward a universal influenza vaccine: from the perspective of protective efficacy
por: Jang, Yo Han, et al.
Publicado: (2013)

The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus
por: Wu, Chia-Ying, et al.
Publicado: (2019)

The influenza vaccines roadmap – A better future through improved influenza vaccines
por: Hart, Peter, et al.
Publicado: (2021)

Options and Obstacles for Designing a Universal Influenza Vaccine
por: Jang, Yo Han, et al.
Publicado: (2014)

Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses
por: Jang, Yo Han, et al.
Publicado: (2021)

Principles underlying rational design of live attenuated influenza vaccines
por: Jang, Yo Han, et al.
Publicado: (2012)

The Future of Influenza Vaccines: A Historical and Clinical Perspective
por: Bouvier, Nicole M.
Publicado: (2018)

The promise of mRNA vaccines: a biotech and industrial perspective
por: Jackson, Nicholas A. C., et al.
Publicado: (2020)

Cross-Protective Immune Responses Elicited by Live Attenuated Influenza Vaccines
por: Jang, Yo Han, et al.
Publicado: (2013)

Development of orphan vaccines: an industry perspective.
por: Lang, J, et al.
Publicado: (1999)

Plant Aspartic Proteases for Industrial Applications: Thistle Get Better
por: Folgado, André, et al.
Publicado: (2020)

Influenza Vaccinations for All Pregnant Women? Better Evidence Is Needed
por: Donzelli, Alberto
Publicado: (2018)

Safety Assessment of 3S, 3’S Astaxanthin Derived from Metabolically Engineered K. marxianus
por: Samuel, Sabrina Yeo, et al.
Publicado: (2022)

Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse
por: Wu, Chia-Ying, et al.
Publicado: (2015)

Predicting Egg Passage Adaptations to Design Better Vaccines for the H3N2 Influenza Virus
por: Liu, Yunsong, et al.
Publicado: (2022)

Veterinary vaccine development from an industrial perspective
por: Heldens, J.G.M., et al.
Publicado: (2008)

Influenza vaccination in HIV-positive subjects: latest evidence and future perspective
por: CERAVOLO, A., et al.
Publicado: (2013)

Industry perspectives on biomarker qualification
por: Lavezzari, G, et al.
Publicado: (2015)

The development of China’s vaccine industry in the past decade: the perspective from drug regulatory science
por: Wang, Guanjie, et al.
Publicado: (2021)

The Quest for a Truly Universal Influenza Vaccine
por: Jang, Yo Han, et al.
Publicado: (2019)

Better adherence to childhood Haemophilus influenzae type b vaccination with combination vaccines compared to single-antigen vaccines: Evidence from China
por: Lai, Xiaozhen, et al.
Publicado: (2023)

Recipe for a Better Tomorrow: A Food Industry Perspective on Sustainability and Our Food System
por: Wasserman, Arlin
Publicado: (2009)

Toward Better Food Security Using Concepts from Industry 5.0
por: Guruswamy, Selvakumar, et al.
Publicado: (2022)

Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective
por: Yang, Guan, et al.
Publicado: (2017)

Influenza in Asthmatics: For Better or for Worse?
por: Veerapandian, Raja, et al.
Publicado: (2018)

Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?
por: Matrajt, Laura, et al.
Publicado: (2020)

Silsesquioxanes in the Cosmetics Industry—Applications and Perspectives †
por: Olejnik, Anna, et al.
Publicado: (2022)

Translational precision medicine: an industry perspective
por: Hartl, Dominik, et al.
Publicado: (2021)

Bat Influenza Viruses: Current Status and Perspective
por: Yang, Wenyu, et al.
Publicado: (2021)

Development and characterization of standard reagents for cell-based prepandemic influenza vaccine products
por: Lai, Chia-Chun, et al.
Publicado: (2020)

School-Based Influenza Vaccination: Parents’ Perspectives
por: Lind, Candace, et al.
Publicado: (2014)

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

Oral Vaccines: A Better Future of Immunization
por: Kwong, Keith Wai-Yeung, et al.
Publicado: (2023)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

Bacillales: From Taxonomy to Biotechnological and Industrial Perspectives
por: Harirchi, Sharareh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lm5scbd83627oabmqo3gpq7e55